SEC 13F Intelligence

Gabelli & Co Investment Advisers, Inc. / 2655787D

Gabelli & Co Investment Advisers, Inc.’s Blueprint Medicines Position

Does Gabelli & Co Investment Advisers, Inc. own Blueprint Medicines (2655787D)? Not currently — the last reported position was 183.4K shares worth $24M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$24M
Q2 2025
Shares
183.4K
% of Portfolio
+3.61%
Quarters Held
1
position exited

Position History 2655787D

Reported value by quarter
Q2 ’25: $24MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025183.4K$24M+3.61%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gabelli & Co Investment Advisers, Inc.’s full portfolio or all institutional holders of 2655787D.